Carlos Tobón

Carlos Tobón

Auto-generated profile, based on publicly available information

Carlos Tobón

Neuroscience Research Group, University of Antioquia, Medellín, Colombia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
Jorge I. VélezJorge I. Vélez
Jorge I. Vélez
FLF Lopera
F Lopera
DSDiego Sepulveda-Falla
Diego Sepulveda-Falla
HPHardip Patel
Hardip Patel
AJA S Johar
A S Johar
MAMauricio Arcos-Burgos
Mauricio Arcos-Burgos
Alzheimer’s disease (AD) age of onset (ADAOO) varies greatly between individuals, with unique causal mutations suggesting the role of modifying genetic and environmental interactions. We analyzed ~50 000 common and rare functional genomic variants from 71 individuals of the ‘Paisa’ pedigree, the world’s largest pedigree segregating a severe form of early-onset AD, who were affected carriers of the fully penetrant E280A mutation in the presenilin-1 (PSEN1) gene. Affected carriers with ages at the extremes of the ADAOO distribution (30s–70s age range), and linear mixed-effects models were used to build single-locus regression models outlining the ADAOO. We identified the rs7412 (APOE*E2 allele) as a whole exome-wide ADAOO modifier that delays ADAOO by ~12 years (β=11.74, 95% confidence interval (CI): 8.07–15.41, P=6.31 × 10−8, PFDR=2.48 × 10−3). Subsequently, to evaluate comprehensively the APOE (apolipoprotein E) haplotype variants (E1/E2/E3/E4), the markers rs7412 and rs429358 were genotyped in 93 AD affected carriers of the E280A mutation. We found that the APOE*E2 allele, and not APOE*E4, modifies ADAOO in carriers of the E280A mutation (β=8.24, 95% CI: 4.45–12.01, P=3.84 × 10−5). Exploratory linear mixed-effects multilocus analysis suggested that other functional variants harbored in genes involved in cell proliferation, protein degradation, apoptotic and immune dysregulation processes (i.e., GPR20, TRIM22, FCRL5, AOAH, PINLYP, IFI16, RC3H1 and DFNA5) might interact with the APOE*E2 allele. Interestingly, suggestive evidence as an ADAOO modifier was found for one of these variants (GPR20) in a set of patients with sporadic AD from the Paisa genetic isolate. This is the first study demonstrating that the APOE*E2 allele modifies the natural history of AD typified by the age of onset in E280A mutation carriers. To the best of our knowledge, this is the largest analyzed sample of patients with a unique mutation sharing uniform environment. Formal replication of our results in other populations and in other forms of AD will be crucial for prediction, follow-up and presumably developing new therapeutic strategies for patients either at risk or affected by AD.

1 January 2016 in Neural Plasticity
Verified
Journal Article
Open access
PDF file
Jorge I. VélezJorge I. Vélez
Jorge I. Vélez
DRDora Rivera
Dora Rivera
CMClaudio A. Mastronardi
Claudio A. Mastronardi
HPHardip Patel
Hardip Patel
CTCarlos Tobón
Carlos Tobón
MAMauricio Arcos-Burgos
Mauricio Arcos-Burgos
We previously reported age of onset (AOO) modifier genes in the world’s largest pedigree segregating early-onset Alzheimer’s disease (AD), caused by the p.Glu280Ala (E280A) mutation in thePSEN1gene. Here we report the results of a targeted analysis of functional exonic variants in those AOO modifier genes in sixty individuals withPSEN1E280A AD who were whole-exome genotyped for ~250,000 variants. Standard quality control, filtering, and annotation for functional variants were applied, and common functional variants located in those previously reported as AOO modifier loci were selected. Multiloci linear mixed-effects models were used to test the association between these variants and AOO. An exonic missense mutation in theG72(DAOA) gene (rs2391191,P= 1.94 × 10−4,PFDR= 9.34 × 10−3) was found to modify AOO inPSEN1E280A AD. Nominal associations of missense mutations in theCLUAP1(rs9790,P= 7.63 × 10−3,PFDR= 0.1832) andEXOC2(rs17136239,P= 0.0325,PFDR= 0.391) genes were also found. Previous studies have linked polymorphisms in theDAOAgene with the occurrence of neuropsychiatric symptoms such as depression, apathy, aggression, delusions, hallucinations, and psychosis in AD. Our findings strongly suggest that this new conspicuous functional AOO modifier within theG72(DAOA) gene could be pivotal for understanding the genetic basis of AD.

10 October 2014 in Social Neuroscience
Verified
Journal Article
Closed access
CTCarlos Tobón
Carlos Tobón
AIAgustin Ibanez
Agustin Ibanez
LVLina Velilla
Lina Velilla
JDJon Duque
Jon Duque
JOJohn Ochoa
John Ochoa
David PinedaDavid Pineda
David Pineda
In this work, the neural correlates of emotional processing in Colombian ex-combatants with different empathy profiles were compared to normal controls matched for age, gender and educational level. Forty ex-combatants and 20 non ex-combatants were recruited for this study. Empathy levels as well as executive functions were measured. Empathy level was used to create three groups. Group 1 (G1) included ex-combatants with normal empathy scores, and Group 2 included ex-combatants with low scores on at least one empathy sub-scales. In control group (Ctrl), participants with no antecedents of being combatants and with normal scores in empathy were included. Age, gender, educational and intelligence quotients level were controlled among groups. event-related potentials (ERPs) were recorded while individuals performed an affective picture processing task that included positive, neutral and negative emotional stimuli, which elicit an early modulation of emotion categorization (Early Posterior Negativity (EPN)) and late evaluative process (LPP). EPN differences were found among affective categories, but no group effects were observed at this component. LPP showed a main effect of category and group (higher amplitudes in ex-combatants). There was an inverse correlation between empathy and executive functions scores and ERPs. Results are discussed according to the impact of emotional processing on empathy profile.

30 August 2016 in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Verified
Journal Article
Closed access
PDF file
Jorge I. VélezJorge I. Vélez
Jorge I. Vélez
FLFrancisco Lopera
Francisco Lopera
HPHardip Patel
Hardip Patel
AJAngad S Johar
Angad S Johar
YCYeping Cai
Yeping Cai
MAMauricio Arcos-Burgos
Mauricio Arcos-Burgos

1 July 2015 in Acta Psychologica
Verified
Journal Article
Closed access
ISIsabel Suarez
Isabel Suarez
BBB. Burle
B. Burle
CTC. Tobon
C. Tobon
David PinedaDavid Pineda
David Pineda
FLF. Lopera
F. Lopera
LCLaurence Casini
Laurence Casini

26 May 2017 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
PDF file
JOJohn Fredy Ochoa-Gómez
John Fredy Ochoa-Gómez
JAJoan Francesc Alonso
Joan Francesc Alonso
JDJon Edinson Duque
Jon Edinson Duque
CTCarlos Andrés Tobón
Carlos Andrés Tobón
ABAna Baena
Ana Baena
AHAlher Mauricio Hernandez
Alher Mauricio Hernandez
Background: Presenilin-1 (PSEN1) mutations are the most common cause of familial early onset Alzheimer’s disease (AD). The PSEN1 E280A (E280A) mutation has an autosomal dominant inheritance and is involved in the production of amyloid-β. The largest family group of carriers with E280A mutation is found in Antioquia, Colombia. The study of mutation carriers provides a unique opportunity to identify brain changes in stages previous to AD. Electroencephalography (EEG) is a low cost and minimally invasiveness technique that enables the following of brain changes in AD. Objective: To examine how previous reported differences in EEG for Theta and Alpha-2 rhythms in E280A subjects are related to specific regions in cortex and could be tracked across different ages. Methods: EEG signals were acquired during resting state from non-carriers and carriers, asymptomatic and symptomatic subjects from E280A kindred from Antioquia, Colombia. Independent component analysis (ICA) and inverse solution methods were used to locate brain regions related to differences in Theta and Alpha-2 bands. Results: ICA identified two components, mainly related to the Precuneus, where the differences in Theta and Alpha-2 exist simultaneously at asymptomatic and symptomatic stages. When the ratio between Theta and Alpha-2 is used, significant correlations exist with age and a composite cognitive scale. Conclusion: Theta and Alpha-2 rhythms are altered in E280A subjects. The alterations are possible to track at Precuneus regions using EEG, ICA, and inverse solution methods.